HSPD1 and prostate carcinoma: Overexpression of HSP60 proved poor prognosis in various carcinomas, including advanced ovarian cancer, head and neck cancer, non-small-cell lung cancer, prostate cancer, gastric cancer, neuroblastoma, bronchial cancer, and colorectal cancer [11].